Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on Interstate 805 Near State Route 905


Motorcycle, Car Collide in Fatal San Diego Accident

Accident Banner

San Diego, CA (April 15, 2020) – One person was killed in a crash in San Diego. The fatal accident occurred on the evening of April 15 on Interstate 805.

A motorcycle and a car collided on southbound Interstate 805, near state Route 905. The crash left debris scattered across all lanes. One person died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#San Diego

#92154


January 30, 2020

Man Injured in Pedestrian Crash at 7th and Webster Streets

Victim Suffers Critical Injuries in Oakland Hit and Run Accident...


December 19, 2019

Teen Injured in Crash on Highway 41 at Ashlan Avenue

Car Rolls Over in Fresno Accident...


October 22, 2019

1 Injured in Crash at Highways 80 and 680

5 Vehicles Involved in Fairfield Accident Fairfield, CA (October 20, 2019) – ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.